Colin Walsh

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 38% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Colin Walsh's trades of Fusion Antibodies PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
414.01
Quantity 68,599
Value £3,365,759
Transaction date
Purchase
Price
363.73
Quantity 56,062
Value £118,733
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-16 2024-10-15
B Purchase
68,599
414.01
£3,365,759 		68,599 414.01 £3,365,759
2024-02-14 2024-02-14
B Purchase
56,062
363.73
£118,733 		56,062 363.73 £118,733